MLL5 Activators

KMT2E Activators, a specific chemical class, encompass compounds that directly or indirectly modulate the activity of the KMT2E protein, a member of the histone methyltransferase family. These activators play a crucial role in epigenetic regulation by influencing histone modification, a key process in the control of gene expression. The primary mechanism of action for these activators involves the alteration of chromatin structure, which governs the accessibility of DNA to transcriptional machinery and thereby regulates gene expression. This modulation can occur through various pathways, including the inhibition of histone deacetylases (HDACs) or DNA methyltransferases, or through the activation of specific signaling pathways like AMP-activated protein kinase (AMPK).

One significant group within KMT2E Activators includes compounds like Resveratrol and Metformin, which activate AMPK. Activation of AMPK by these compounds leads to changes in cellular energy status, subsequently impacting chromatin remodeling and histone modification. This alteration in chromatin architecture directly affects gene expression patterns, thereby modulating the activity of KMT2E. Another important category within this class is HDAC inhibitors, such as Sodium Butyrate, Trichostatin A, and SAHA (Vorinostat). These compounds induce hyperacetylation of histones, leading to a more open chromatin structure, which facilitates transcription and can influence KMT2E function. Furthermore, compounds like 5-Aza-2'-deoxycytidine, which inhibits DNA methyltransferases, alter DNA methylation patterns, a key component of the epigenetic regulation mechanism. These changes can have downstream effects on histone modification and KMT2E activity.